---
title: "Dujohn Laboratories Ltd (507482) — Share Price, Financials & Analysis"
symbol: "507482"
company: "Dujohn Laboratories Ltd"
canonical: "https://tapetide.com/stocks/507482"
isin: "INE990A01014"
bse_code: "507482"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:58:13.888Z"
---

# Dujohn Laboratories Ltd (507482)

Canonical page: https://tapetide.com/stocks/507482

## Company

- **BSE Code:** 507482
- **ISIN:** INE990A01014
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Growth Rates

| Metric | 1Y |
| --- | --- |
| net income growth | -100% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 | TTM |
| --- | --- | --- | --- |
| Sales | 0 | 0 | 0 |
| Expenses | 0.01 | 0.02 | 0 |
| Operating Profit | -0.01 | -0.02 | 0 |
| Other Income | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 |
| Profit before tax | -0.01 | -0.02 | 0 |
| Tax % | 0 | 0 | — |
| Net Profit | -0.01 | -0.02 | 0 |
| Dividend Payout % | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 |
| --- | --- | --- |
| Equity Capital | 3.51 | 3.51 |
| Reserves | -4.3 | -4.32 |
| Borrowings | 4.15 | 4.16 |
| Other Liabilities | 2.24 | 2.24 |
| Total Liabilities | 5.6 | 5.59 |
| Fixed Assets | 3.02 | 3.02 |
| CWIP | 0 | 0 |
| Investments | 0.01 | 0.01 |
| Other Assets | 2.57 | 2.56 |
| Total Assets | 5.6 | 5.59 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2009 | Mar 2010 |
| --- | --- | --- |
| Cash from Operating Activity | 0 | 0 |
| Cash from Investing Activity | 0 | 0 |
| Cash from Financing Activity | 0 | 0 |
| Net Cash Flow | 0 | 0 |
| Free Cash Flow | 0 | 0 |
| CFO/OP | 0 | 0 |

### Ratios

| Item | Mar 2009 | Mar 2010 |
| --- | --- | --- |
| ROCE % | — | -0.6 |

## Shareholding Pattern

### annual

| Category | Mar 2025 | Sep 2025 |
| --- | --- | --- |
| Promoters | 62.86% | 62.86% |
| Public | 37.14% | 37.15% |
| No. of Shareholders | 805 | 704 |

### Quarterly

| Category | Sep 2024 | Oct 2024 | Mar 2025 | Sep 2025 |
| --- | --- | --- | --- | --- |
| Promoters | 62.86% | 62.86% | 62.86% | 62.86% |
| Public | 37.13% | 37.13% | 37.14% | 37.15% |
| No. of Shareholders | 1466 | 1466 | 805 | 704 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 720.52 | Sell |
| EMA (10) | 714.21 | Sell |
| SMA (20) | 744.2 | Sell |
| EMA (20) | 734.87 | Sell |
| SMA (50) | 769.26 | Sell |
| EMA (50) | 760.06 | Sell |
| SMA (100) | 776.7 | Sell |
| EMA (100) | 769.9 | Sell |
| SMA (200) | 770.12 | Sell |
| EMA (200) | 773.08 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 30.62 | Neutral |
| MACD (12,26,9) | -23.21 | Sell |
| Stochastic (14,3,3) | 9.76 | Buy |
| ADX (14) | 22.11 | Neutral |
| Williams %R (14) | -89.64 | Buy |
| ATR (14) | 25.37 | High Volatility |
| ROC (12) | -9.82 | Sell |
| Stoch RSI (14) | 16.86 | Buy |
| UO (7,14,28) | 40.34 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 30 Jan - Board approved acquiring 51% of Nascent Global Impex LLP; cash consideration to be finalized; completion within three months. | [Board Meeting Outcome for Outcome Of Board Meeting 30 Jan - Board approved acquiring 51% of Nascent Global Impex LLP; cash consideration to be finalized; completion within three months.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d9ecebb3-801f-45af-ad45-e90e8af20863.pdf) |
| 14 Nov 2025 - IPO funds total 1,829.52 lakh; Rs 12.80 lakh overutilised in issue expenses, adjusted. | [SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (''''''''IPO") 14 Nov 2025 - IPO funds total 1,829.52 lakh; Rs 12.80 lakh overutilised in issue expenses, adjusted.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/63a29e75-00ca-4619-bcb6-d2774386c9f9.pdf) |
| 14 Nov 2025 - Board approved 51% JV acquisition for Rs12.41Cr and proposed Rs16.56Cr Mahape godown purchase; Q2 results. | [Board Meeting Outcome for Board Metting Outcome For Submission Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025 14 Nov 2025 - Board approved 51% JV acquisition for Rs12.41Cr and proposed Rs16.56Cr Mahape godown purchase; Q2 results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d370cc90-dcc2-4a72-a516-86201d37d745.pdf) |
| 12 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 for the quarter Ended 31st December 2025 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Jan - Certificate under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 for the quarter Ended 31st December 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d7e83b7-cfdd-403a-8527-16aba78516d2.pdf) |
| — | [Unaudited Financial Results For The Half Year Ended September 30, 2025. 14 Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dc51dfc6-bd10-4810-898c-b6fefb6b6d31.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b0d7cd7e-1f31-432f-9d35-bb622268e944.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:13.888Z.